Ebr Sys Inc EBRCZ

$0.12 +0.00 (2.53%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
PE ratio
—
Forward PE
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
10,000
Avg volume
16,474
Day's range
$0.12 – $0.12
Shares out
—
Stochastic %K
13%
Beta
—
Analysts
Strong Buy
Price target
—

Price

Company profile

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an in...

Show more

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.

Industry
Medical Devices
Sector
Healthcare
Phone
408 720 1906
Website
https://www.ebrsystemsinc.com
Address
480 Oakmead Parkway, Sunnyvale, United States

Latest news

No headlines yet.